Explore more publications!

Health Digest Cook Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Digest Cook Islands.

Press releases published on March 12, 2026

Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
The Joint Corp. Reports 2025 Fourth Quarter and Full Year Financial Results
Picard Medical / SynCardia to Host Annual Business Update Featuring Key Opinion Leaders and Patient Testimonial
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update 
BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement
Koelis stellt auf der EAU 2026 innovative Produkte vor, die die Arbeitsabläufe bei der MRT-Fusionsbiopsie verbessern und die fokale Therapie bei Prostatakrebs fördern

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions